Kane Biotech (TSE:KNE) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Kane Biotech honors the legacy of the late Dr. Greg Schultz with the launch of the Schultz Biofilm Wound Map, a pioneering in vitro detection kit for biofilms in wound beds. This tool is poised to significantly advance the treatment of chronic wounds and is a testament to Dr. Schultz’s impactful work at Kane Biotech, where he was instrumental in developing key antimicrobial technologies. The company’s commitment to combating biofilm-related problems in healthcare continues with this innovative tribute to their former Chief Science Officer.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
